Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

Diabetol Int. 2020 Apr 23;11(4):393. doi: 10.1007/s13340-020-00436-8. eCollection 2020 Oct.

Affiliations

¹ Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Japan.
² Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505 Japan.

Abstract

[This corrects the article DOI: 10.1007/s13340-020-00434-w.].

© The Japan Diabetes Society 2020.

Publication types

Published Erratum